PORTUGAL; SWEDEN —European life science conglomerate AddLife has completed the purchase of MoonSurge, Importação e Exportação de Material Médico, LDA, a Portuguese distributor specializing in high-technology medical devices for advanced surgical applications. The transaction, which closed on November 2, 2026, positions the acquired entity as an independent subsidiary under MBA Surgical Empowerment, an operating unit within AddLife's Medtech division.
MoonSurge delivers surgical equipment and solutions targeting general surgery, urology, gynaecology, and cardiac procedures, focusing primarily on minimally invasive techniques. The company maintains an annual turnover of approximately EUR 5 million and operates with a workforce of 14 personnel in Portugal, supplying hospital institutions and clinical practitioners with specialized technologies sourced from leading European manufacturers.
This transaction holds significant weight for the European medical technology sector by highlighting ongoing consolidation trends among specialized distribution networks in Southern Europe. For clinical institutions and healthcare providers, the integration bridges regional distribution capabilities with broader corporate resources, ensuring continued access to specialized surgical innovations. The deal directly impacts medical device manufacturers seeking established commercial channels within the Iberian Peninsula, as well as competitors operating within specialized surgical distribution markets.
From a strategic investment standpoint, the acquisition aligns with AddLife's stated corporate objective to expand its presence within high-margin, technically advanced product categories that offer long-term organic and inorganic growth potential. By leveraging the existing infrastructure and regional relationships of its Spanish subsidiary MBA Surgical Empowerment, the parent organization aims to capture synergies across the Iberian market while generating a marginal positive contribution to earnings per share for the current financial year.
AddLife operates as an independent partner within the European life science sector, supplying specialized products, advisory services, and technical equipment to both public and private healthcare segments. The Stockholm-listed group maintains a network of approximately 85 operating subsidiaries and a collective workforce exceeding 2,000 personnel, generating net revenues surpassing SEK 10 billion.
